← Eichor
Condition: Biliary Tract Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Biliary Tract Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic C
NA · 8 location(s) · Aichi Medical University · NCT07235007Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · Hangzhou Hanx Biopharmaceuticals, Ltd. · NCT06708663Study for AZD4360 in Participants With Advanced Solid Tumours
Phase 1/Phase 2 · 18 location(s) · AstraZeneca · NCT06921928Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Phase 3 · 3 location(s) · Rajiv Gandhi Cancer Institute & Research Center, India · NCT06712420Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT07673861A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · 43 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
NA · 1 location(s) · Zhejiang University · NCT07480785The Study of Association of Helicobacter Infections in Biliary Tract Cancers
Phase N/A · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06909188The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03637569This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Tor
Phase 1 · 3 location(s) · Zumutor Biologics Inc. · NCT06451497Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
Phase 2/Phase 3 · 5 location(s) · InnoPharmax Inc. · NCT05065957Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Phase 2/Phase 3 · 1 location(s) · Banaras Hindu University · NCT05833815Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
NA · 6 location(s) · Hospital Universitari de Bellvitge · NCT04735198At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT06060990Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 11 location(s) · TiumBio Co., Ltd. · NCT05784688Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Phase 2 · 2 location(s) · Case Comprehensive Cancer Center · NCT07146646Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Phase N/A · 1 location(s) · Herlev and Gentofte Hospital · NCT05184400Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
Phase 1 · 2 location(s) · University of Maryland, Baltimore · NCT06546969Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Phase 1/Phase 2 · 11 location(s) · Genfit · NCT05874414CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06937567A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast G
Phase N/A · 1 location(s) · Eisai Co., Ltd. · NCT06793709Personalized Medicine for Advanced Biliary Cancer Patients
Phase 3 · 69 location(s) · UNICANCER · NCT05615818Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NA · 2 location(s) · Nantes University Hospital · NCT06735560Efficacy and Safety of Surgical Treatment for Type IVa CBD
Phase N/A · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07036848Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT07473687Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy
Phase 2 · 1 location(s) · Asan Medical Center · NCT05222971A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction
Phase N/A · 3 location(s) · Wuhan Children's Hospital · NCT07530354
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.